학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 76건 | 목록 1~20
Le Rhun E; Department of Neurosurgery, Clinical Neuroscience Center, University Hospital and University of Zurich, Zurich, Switzerland; Department of Neurology, Clinical Neuroscience Center, University Hospital and University of Zurich, Zurich, Switzerland; Neuro-Oncology, General and Stereotaxic Neurosurgery Service, University Hospital of Lille, Lille, France; University of Lille, Inserm, U-1192 Lille, France. Electronic address: emilie.lerhun@usz.ch.; Gorlia T; European Organization for Research and Treatment of Cancer, Brussels, Belgium.; Felsberg J; Institute of Neuropathology, Medical Faculty, Heinrich Heine University and University Hospital Düsseldorf, and German Cancer Consortium (DKTK), Partner Site Essen/Düsseldorf, Düsseldorf, Germany.; Jongen J; The Brain Tumour Center at the Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; Maurage CA; Univ. Lille, UFR3S - Laboratoire d'Histologie, Lille, France.; Ducray F; CHU Lyon, Neuro-Oncology, Lyon, France.; Gramatzki D; Department of Neurology, Clinical Neuroscience Center, University Hospital and University of Zurich, Zurich, Switzerland.; Hau P; Department of Neurology - NeuroOncology and Wilhelm Sander Neuro-Oncology Unit, University Hospital Regensburg, Regensburg, Germany.; Chinot OL; Neuro-oncology, CHU Timone, Marseille, France.; Preusser M; Division of Oncology, Department of Medicine 1, Medical University, Vienna, Austria.; Cartalat S; CHU Lyon, Neuro-Oncology, Lyon, France.; Roth P; Department of Neurology, Clinical Neuroscience Center, University Hospital and University of Zurich, Zurich, Switzerland.; van den Bent M; The Brain Tumour Center at the Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; Furtner J; Department of Biomedical imaging and Image-guided Therapy, Medical University of Vienna, Austria; Research Center for Medical Image Analysis and Artificial Intelligence (MIAAI), Faculty of Medicine and Dentistry, Danube Private University, 3500 Krems, Austria.; Collienne M; European Organization for Research and Treatment of Cancer, Brussels, Belgium.; Reifenberger G; Institute of Neuropathology, Medical Faculty, Heinrich Heine University and University Hospital Düsseldorf, and German Cancer Consortium (DKTK), Partner Site Essen/Düsseldorf, Düsseldorf, Germany.; Weller M; Department of Neurology, Clinical Neuroscience Center, University Hospital and University of Zurich, Zurich, Switzerland.
Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE; PubMed not MEDLINE
Academic Journal
Tesileanu CMS; Department of Neurology, Brain Tumor Center at Erasmus MC Cancer Institute Rotterdam, PO Box 2040, 3000 CA, Rotterdam, The Netherlands.; Vallentgoed WR; Department of Neurology, Brain Tumor Center at Erasmus MC Cancer Institute Rotterdam, PO Box 2040, 3000 CA, Rotterdam, The Netherlands.; Sanson M; Sorbonne Universités UPMC University of Paris 06, Inserm, CNRS, APHP, Institut du Cerveau et de la Moelle (ICM)-Hôpital Pitié-Salpêtrière, Boulevard de l'hôpital, 75013, Paris, France.; Taal W; Department of Neurology, Brain Tumor Center at Erasmus MC Cancer Institute Rotterdam, PO Box 2040, 3000 CA, Rotterdam, The Netherlands.; Clement PM; Department of Oncology, KU Leuven, Leuven, Belgium.; Department of General Medical Oncology, UZ Leuven, Leuven, Belgium.; Wick W; Neurologische Klinik und Nationales Zentrum für Tumorerkrankungen Universitätsklinik, Heidelberg, Germany.; Brandes AA; Medical Oncology Department, AUSL-IRCCS Scienze Neurologiche, Bologna, Italy.; Baurain JF; Medical Oncology Department, King Albert II Cancer Institute, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Bruxelles, Belgium.; Chinot OL; Neuro-Oncology Division, Aix-Marseille University, AP-HM, Marseille, France.; Wheeler H; Northern Sydney Cancer Centre, St Leonards, NSW, 2065, Australia.; Gill S; Department Medical Oncology, Alfred Hospital, Melbourne, Australia.; Griffin M; Department of Clinical Oncology, Nottingham University Hospitals NHS Trust, Nottingham, UK.; Rogers L; Department of Radiation Oncology, Barrow Neurological Institute, Phoenix, AZ, USA.; Rudà R; Department of Neuro-Oncology, City of Health and Science Hospital and University of Turin, Turin, Italy.; Weller M; Department of Neurology and Brain Tumor Center, University Hospital and University of Zurich, Zurich, Switzerland.; McBain C; Department of Clinical Oncology, The Christie NHS FT, Manchester, UK.; Reijneveld J; Brain Tumor Center Amsterdam and Department of Neurology, Amsterdam University Medical Center, Amsterdam, The Netherlands.; Enting RH; Department of Neurology, UMCG, University of Groningen, Groningen, The Netherlands.; Caparrotti F; Department of Radiation Oncology, University Hospital of Geneva, Geneva, Switzerland.; Lesimple T; Department of Clinical Oncology, Comprehensive Cancer Center Eugène Marquis, Rennes, France.; Clenton S; Weston Park Hospital, Sheffield, UK.; Gijtenbeek A; Department of Neurology, Radboud University Medical Centre, Nijmegen, The Netherlands.; Lim E; Department of Clinical Oncology, Plymouth Hospitals NHS Trust, Plymouth, UK.; de Vos F; Department of Medical Oncology, UMC Utrecht Cancer Center, Utrecht, The Netherlands.; Mulholland PJ; University College Hospital, London, UK.; Taphoorn MJB; MC Haaglanden, Den Haag, The Netherlands.; de Heer I; Department of Neurology, Brain Tumor Center at Erasmus MC Cancer Institute Rotterdam, PO Box 2040, 3000 CA, Rotterdam, The Netherlands.; Hoogstrate Y; Department of Neurology, Brain Tumor Center at Erasmus MC Cancer Institute Rotterdam, PO Box 2040, 3000 CA, Rotterdam, The Netherlands.; de Wit M; Department of Neurology, Brain Tumor Center at Erasmus MC Cancer Institute Rotterdam, PO Box 2040, 3000 CA, Rotterdam, The Netherlands.; Boggiani L; Department of Neurology, Brain Tumor Center at Erasmus MC Cancer Institute Rotterdam, PO Box 2040, 3000 CA, Rotterdam, The Netherlands.; Venneker S; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.; Oosting J; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.; Bovée JVMG; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.; Erridge S; Edinburgh Centre for Neuro-Oncology, Western General Hospital, University of Edinburgh, Edinburg, UK.; Vogelbaum MA; Department of NeuroOncology, Moffitt Cancer Center, Tampa, FL, USA.; Nowak AK; School of Medicine and Pharmacology, University of Western Australia, 35 Stirling, Highway Crawley, WA, 6009, Australia.; CoOperative Group for NeuroOncology, University of Sydney, Camperdown, NSW, Australia.; Department of Medical Oncology, Sir Charles Gairdner Hospital, Hospital Avenue, Nedlands, WA, 6009, Australia.; Mason WP; Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada.; Kros JM; Department of Pathology, Erasmus University Medical Center, Rotterdam, The Netherlands.; Wesseling P; Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands.; Aldape K; Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada.; Jenkins RB; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.; Dubbink HJ; Department of Pathology, Erasmus University Medical Center, Rotterdam, The Netherlands.; Baumert B; Department of Radiation-Oncology (MAASTRO), Maastricht University Medical Center (MUMC) and GROW (School for Oncology), Maastricht, The Netherlands.; Institute of Radiation-Onology, Chur, Switzerland.; Golfinopoulos V; EORCT HQ, Brussels, Belgium.; Gorlia T; EORCT HQ, Brussels, Belgium.; van den Bent M; Department of Neurology, Brain Tumor Center at Erasmus MC Cancer Institute Rotterdam, PO Box 2040, 3000 CA, Rotterdam, The Netherlands.; French PJ; Department of Neurology, Brain Tumor Center at Erasmus MC Cancer Institute Rotterdam, PO Box 2040, 3000 CA, Rotterdam, The Netherlands. p.french@erasmusmc.nl.
Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0412041 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0533 (Electronic) Linking ISSN: 00016322 NLM ISO Abbreviation: Acta Neuropathol Subsets: MEDLINE
Academic Journal
Muracciole X; Radiotherapy Department, Assistance Publique des Hôpitaux de Marseille, Marseille, France.; El-Amine W; Radiotherapy Department, Assistance Publique des Hôpitaux de Marseille, Marseille, France.; Tabouret E; Neuro-Oncology Department, Assistance Publique des Hôpitaux de Marseille, Marseille, France.; Angiogenesis and Micro Environnment UMR 911 CRO2, Aix-Marseille University, Marseille, France.; Boucekine M; Unity of Research EA3279, Aix-Marseille Université, Marseille, France.; Barlier A; Molecular Biology and Oncogenetics Department, Assistance Publique des Hôpitaux de Marseille, Marseille, France.; Petrirena G; Neuro-Oncology Department, Assistance Publique des Hôpitaux de Marseille, Marseille, France.; Harivony T; Radiotherapy Department, Assistance Publique des Hôpitaux de Marseille, Marseille, France.; Solignac L; Radiotherapy Department, Assistance Publique des Hôpitaux de Marseille, Marseille, France.; Chinot OL; Neuro-Oncology Department, Assistance Publique des Hôpitaux de Marseille, Marseille, France.; Macagno N; Angiogenesis and Micro Environnment UMR 911 CRO2, Aix-Marseille University, Marseille, France.; Neuropathology Department, Assistance Publique des Hôpitaux de Marseille, Marseille, France.; Figarella-Branger D; Angiogenesis and Micro Environnment UMR 911 CRO2, Aix-Marseille University, Marseille, France.; Neuropathology Department, Assistance Publique des Hôpitaux de Marseille, Marseille, France.; Padovani L; Radiotherapy Department, Assistance Publique des Hôpitaux de Marseille, Marseille, France.; CRCM INSERM UMR1068, CNRS UMR7258 AMU UM105, Genome Instability and Carcinogenesis, Institut Paoli-Calmettes, Marseille, France.
Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
검색 결과 제한하기
제한된 항목
[AR] Chinot, Olivier L
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어